• New indications refer to news indicating that an existing drug may have a wider range of medical applications.

  • Repurposing existing drugs in this way may be less costly than developing new drugs from scratch.
  • Investors often view new signs as bullish, expecting the company in question to access new revenue streams at relatively low cost.